Market Place
Sourcing Support
Iambic Names Peter Olson, Ph.D., As Chief Scientific Officer
11 Dec 2024 //
BUSINESSWIRE
Iambic Therapeutics Launches “Enchant,” an AI Platform
29 Oct 2024 //
BUSINESSWIRE
Iambic Therapeutics Named To Endpoints 11 List Of Startups
27 Sep 2024 //
BUSINESSWIRE
Iambic Therapeutics Welcomes Dr. Mary Tagliaferri to Board of Directors
05 Sep 2024 //
BUSINESSWIRE
Iambic Closes $50M Series B To Broaden AI-Discovered Oncology Pipeline
18 Jun 2024 //
BUSINESSWIRE
Iambic Her2 Iam1363 Poster: Clinical Stage At Asco 2024
23 May 2024 //
BUSINESSWIRE
Iambic Selects Lambda For Generative AI Drug Discovery Compute Demands
14 May 2024 //
BUSINESSWIRE
Iambic to Present New Pre-Clinical Data for IAM1363 at the AACR Annual Meeting
28 Mar 2024 //
BUSINESSWIRE
Iambic Announces New Research Published in Nature Machine Intelligence
12 Feb 2024 //
BUSINESSWIRE
AI-driven biotech Iambic snags $100M to enter the clinic next year in HER2 field
03 Oct 2023 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.